Publications by authors named "E Amjadi"

Background: Triple-negative breast cancer (TNBC) is a leading cause of cancer-related mortality among women, with a poor prognosis. The programmed cell death 1 (PD-1) pathway has emerged as a potential immunotherapy target. This study aimed to assess PD-L1 expression in TNBC patients and its relationship with prognostic variables.

View Article and Find Full Text PDF

Introduction: Both ketamine (KET) and medial prefrontal cortex (mPFC) deep brain stimulation (DBS) are emerging therapies for treatment-resistant depression, yet our understanding of their electrophysiological mechanisms and biomarkers is incomplete. This study investigates aperiodic and periodic spectral parameters, and the signal complexity measure sample entropy, within mPFC local field potentials (LFP) in a chronic corticosterone (CORT) depression model after ketamine and/or mPFC DBS.

Methods: Male rats were intraperitoneally administered CORT or vehicle for 21 days.

View Article and Find Full Text PDF

Background: Cancer development is aided by the role of long noncoding RNAs (lncRNAs) that act as competing endogenous RNAs (ceRNAs) absorbing microRNAs (miRNAs). We aimed to discover a novel regulatory axis in colorectal cancer (CRC) and potential biomarkers based on miR-616-3p.

Materials And Methods: The gene expression omnibus database was mined for differentially expressed lncRNAs (DELs) and mRNAs.

View Article and Find Full Text PDF
Article Synopsis
  • Adenoma detection rate (ADR) is a key measure in assessing the quality of colorectal cancer screening, with a study analyzing polyp detection rates (PDR) and ADR among various age groups over a seven-year period in Iran.
  • Out of 1,676 participants, it was found that older age groups (51-59 and ≥60) and high-risk patients had significantly higher PDR and ADR compared to average-risk patients, and men showed higher detection rates than women in certain age groups.
  • The overall trend indicated an increase in ADR during the study period, highlighting the importance of tailored screening approaches based on individual risk levels, age, and sex.
View Article and Find Full Text PDF

Background: Long noncoding RNAs (lncRNAs) have been recognized as the main modulatory molecules in various cancers and perform as competing endogenous RNAs (ceRNAs). The nuclear hormone receptor superfamily of ligand-activated transcription factors (NR3C1) regulates numerous proliferative and metabolic processes such as tumorigenesis and metabolic diseases. Furthermore, X-linked inhibitor of apoptosis protein (XIAP) belongs to a family of the inhibitors of apoptosis proteins, is located downstream of the glucocorticoid receptor (GR or NR3C1) pathway, and cooperates with GR to suppress apoptosis.

View Article and Find Full Text PDF